Related Experiment Video
Updated: Jul 19, 2025

Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery
Published on: June 28, 2019
Tail engagement of arrestin at the glucagon receptor
Kun Chen1,2, Chenhui Zhang1,2, Shuling Lin1
1State Key Laboratory of Drug Research, State Key Laboratory of Chemical Biology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
Abstract:
Arrestins have pivotal roles in regulating G protein-coupled receptor (GPCR) signalling by desensitizing G protein activation and mediating receptor internalization1,2. It has been proposed that the arrestin binds to the receptor in two different conformations, 'tail' and 'core', which were suggested to govern distinct processes of receptor signalling and trafficking3,4. However, little structural information is available for the tail engagement of the arrestins. Here we report two structures of the glucagon receptor (GCGR) bound to β-arrestin 1 (βarr1) in glucagon-bound and ligand-free states. These structures reveal a receptor tail-engaged binding mode of βarr1 with many unique features, to our knowledge, not previously observed. Helix VIII, instead of the receptor core, has a major role in accommodating βarr1 by forming extensive interactions with the central crest of βarr1. The tail-binding pose is further defined by a close proximity between the βarr1 C-edge and the receptor helical bundle, and stabilized by a phosphoinositide derivative that bridges βarr1 with helices I and VIII of GCGR. Lacking any contact with the arrestin, the receptor core is in an inactive state and loosely binds to glucagon. Further functional studies suggest that the tail conformation of GCGR-βarr governs βarr recruitment at the plasma membrane and endocytosis of GCGR, and provides a molecular basis for the receptor forming a super-complex simultaneously with G protein and βarr to promote sustained signalling within endosomes. These findings extend our knowledge about the arrestin-mediated modulation of GPCR functionalities.
Insights
This study reveals unique structural insights into how β-arrestin 1 (βarr1) binds to the glucagon receptor (GCGR) via its tail. These findings clarify arrestin-mediated signaling and receptor trafficking for G protein-coupled receptors (GPCRs).
Area of Science:
- Structural Biology
- Molecular Pharmacology
- Cellular Signaling
Background:
- Arrestins regulate G protein-coupled receptor (GPCR) signaling and internalization.
- Two proposed arrestin binding conformations (tail and core) influence distinct receptor processes.
- Limited structural data exists for arrestin's tail engagement with receptors.
Purpose of the Study:
- To determine the structural basis of β-arrestin 1 (βarr1) binding to the glucagon receptor (GCGR) in different states.
- To elucidate the role of the tail-engaged binding mode in receptor signaling and trafficking.
Main Methods:
- Determined two structures of glucagon receptor (GCGR) bound to β-arrestin 1 (βarr1) using X-ray crystallography.
- Analyzed structural features of the tail-engaged βarr1-GCGR complex.
- Conducted functional studies to assess the role of the tail conformation in receptor regulation.
Main Results:
- Revealed a novel tail-engaged binding mode of βarr1 to GCGR, distinct from previously observed interactions.
- Identified extensive interactions between GCGR's Helix VIII and βarr1's central crest.
- Demonstrated that a phosphoinositide derivative stabilizes the βarr1-GCGR complex.
- Showed the receptor core remains inactive and loosely bound to glucagon in the tail-engaged state.
- Established that the tail conformation governs βarr recruitment, GCGR endocytosis, and sustained signaling.
Conclusions:
- The tail-engaged binding of βarr1 to GCGR involves unique structural features, particularly interactions with Helix VIII.
- This binding mode is critical for regulating receptor membrane recruitment, endocytosis, and intracellular signaling.
- Provides a molecular framework for understanding how GPCRs form super-complexes for sustained signaling.
Related Concept Videos
GPCRs Regulate Adenylyl Cylase Activity
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Insulin: The Receptor and Signaling Pathways
cAMP-dependent Protein Kinase Pathways
GPCR Desensitization
Amplifying Signals via Enzymatic Cascade

